Lifecore Biomedical, Inc. (LFCR) financial statements and ratios from SEC XBRL: revenue $75.52M (TTM), net margin -23.8%, revenue growth -6.2% YoY. Income statement, balance sheet, cash flow, and valuation. First-party data.
| Revenue (TTM) | $75.52M |
| Net Margin | -23.8% |
| Revenue Growth (YoY) | -6.2% |
| EPS Growth (YoY) | 216.7% |
| FCF Growth (YoY) | -185.4% |
| EV / EBITDA | 35.1 |
| Price / Sales | 1.38 |
| FCF Yield | 2.0% |
| Altman Z-Score | -0.31 (distress) |
| Piotroski F-Score | 3/9 |
| Sector P/E (Healthcare) | 21.7 |
LFCR overview · LFCR earnings · LFCR KPIs · LFCR investor relations · LFCR ownership · LFCR peers · LFCR filings
Data sourced from U.S. SEC EDGAR XBRL filings. Not personalized investment advice.